Kaya Holdings, Inc.’s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A.
May 24, 2023
Ryan Allway May 24th, 2023 Psychedelics, Top News KAYS’ Fifth Dimension Therapeutics Plans to Open “The Sacred Mushroom™” Psilocybin Centers in Oregon, Marking Entry into the Global Psychedelics Market, which is Forecast to Exceed $8 Billion by 2029. FT. LAUDERDALE, FL / ACCESSWIRE / May 24, 2023 / Kaya Holdings,... Read more
Study after study shows a correlation between cannabis use and depression, though prohibitionists or federal organizations sometimes use them to discourage cannabis use.
The post Depressed? These Marijuana Strains Might Help appeared first on The Cannifornian.
Read more
Ryan Allway December 10th, 2021 Psychedelics, Top Story Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) set out to build a nationwide network of psychedelic-assisted psychotherapy clinics in 2018. Since then, the company has grown its footprint to ten clinics across six states exceeding 60,650 sq.... Read more
Cognetivity Neurosciences Partners with Ketamine One in Collaborative Clinical Study on Depression and PTSD
December 2, 2021
Ryan Allway December 2nd, 2021 Psychedelics Research study follows deployment of Cognetivity’s ICA in Ketamine One’s North American clinics and will open up novel, tailored use cases in burgeoning mental health market VANCOUVER, BC, Dec. 2, 2021 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity“) (CSE: CGN) (OTCQB: CGNSF) (FWB:... Read more
Ketamine Offers Promise to Veterans with PTSD
September 24, 2021
Ryan Allway September 24th, 2021 App, Exclusive, Psychedelics, Top Story Post-traumatic stress disorder, or PTSD, is a common mental illness among veterans. According to the Department of Veteran Affairs, 11% to 30% of veterans who served in foreign wars experience PTSD, far higher than the estimated 6% of the... Read more
MedXtractor Fills a Key Gap in Mental Health Treatments
June 30, 2021
Ryan Allway June 30th, 2021 App, Exclusive, Psychedelics, Top News According to the Lancet Commission, mental health disorders are on the rise in every country worldwide, and the resulting lost productivity will cost the global economy $16 trillion by 2030. Yet, despite nearly two billion people with mental illness... Read more
Microdosing: The Next Revolution in Psychedelics
April 22, 2021
Ryan Allway April 22nd, 2021 App, Exclusive, Psychedelics, Top Story The psychedelics industry has experienced a renaissance over the past few years as researchers have opened a pandora’s box of potential. From major depression to generalized anxiety to post-traumatic stress disorder, emerging research suggests that psychedelic substances could have... Read more
Robin Lefferts April 3rd, 2020 App, Exclusive, News, Top News What is the ideal setting for a brand to showcase its wares to the retail consumer? It is certainly not a crowded store with hundreds of brands competing for limited shelf space and consumer attention. Every brand out there... Read more
Psychedelics: Investing in the Perfect BrainStorm
April 3, 2020
Ryan Allway April 3rd, 2020 App, Exclusive, News, Top Story Psychedelics are rapidly becoming both a mainstream treatment option and investment opportunity. With growing interest among researchers, forward-thinking companies are starting to build a presence in the space. In this article, we will take a look at the growing... Read more
Psychedelics, the Next Frontier in Drug Research
February 28, 2020
Ryan Allway February 28th, 2020 App, Exclusive, News, Top Story A big factor in the recent rise of cannabis legalization is the emergence of legitimate scientific research into the potential health benefits of the plant’s active ingredients, called cannabinoids. Medicines are often derived from naturally occurring compounds, from aspirin... Read more
